CNBC Jim Cramer's top 10 things to watch in the stock market Tuesday
The S&P 500 was little changed this morning, while Novo Nordisk shares rose after its obesity pill secured FDA approval.
The S&P 500 was little changed this morning, while Novo Nordisk shares rose after its obesity pill secured FDA approval.